Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-01-09T16:03:33.875Z Has data issue: false hasContentIssue false
  • English
  • Français

Recurrence of oropharyngeal carcinoma after radiotherapy

Published online by Cambridge University Press:  29 June 2007

Laura Viani ,
Patrick Dammeijer ,
A. S. Jones ,
J. E. Dalby  and
P. M. Stell
Laura Viani
Affiliation:
Department of Otorhinolaryngology, University of Liverpool.
Patrick Dammeijer
Affiliation:
Department of Otorhinolaryngology, University of Liverpool.
A. S. Jones
Affiliation:
Department of Otorhinolaryngology, University of Liverpool.
J. E. Dalby
Affiliation:
Depament of Radiotherapy and Oncology, Clatterbridge Hospital, Clatterbridge Road, Bebington, Wirral L63 4JY.
P. M. Stell*
Affiliation:
Department of Otorhinolaryngology, University of Liverpool.
*
Professor P. M. Stell, Department of Otorhinolaryngology, University of Liverpool, P0 Box 147, Liverpool L69 3BX.
Get access Rights & Permissions [Opens in a new window]

Abstract

Two-hundred-and-twenty-one patients with squamous carcinoma of the oropharynx treated by irradiation are presented.

The primary recurrence rate at five years in the previously untreated patients was 27%, but was dictated by neither host factors (age, sex and general condition) nor tumour factors (site, T-stage and histological grade).

Pre-operative histological diagnosis had a very high sensitivity but a low specificity, indicating that false positives are common but false negatives unusual. Twenty per cent of patients with a recurrent primary tumour were untreatable.

The five year survival after a primary recurrence was 31 per cent. Sixty-eight per cent of patients undergoing major surgery recovered without a major complication, and the hospital mortality rate was three per cent, due entirely to major medical catastrophes. The major complication rate in those undergoing flap repair after major resection was seven percent.

The metastatic rate in lymph nodes was 44 per cent at five years, and again this did not depend on any host or tumour factors. The survival at five years after node recurrence was a mere 19 per cent, and the length of survival was related to the primary site of the original tumour and the presence of extranodal disease. Two-thirds of patients had advanced disease (N2 and N3) when node recurrence was diagnosed and about 15 percent were unsuitable for surgery.

Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 105 , Issue 1 , January 1991 , pp. 24 - 28
Copyright
Copyright © JLO (1984) Limited 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Joint Committee on Cancer (1988), 3rd edition. J. B. Lippincott Company, New York.Google Scholar
Armitage, P. (1987) Statistical methods in medical research. Blackwell Scientific Publications: 2nd Edition, Oxford, p. 422.Google Scholar
Conley, J. (1970) Concepts in head and neck surgery. Georg Thieme Verlag, Stuttgart.Google Scholar
Fletcher, G. H., Jesse, R. H., Healey, J. E. Jr, Thomas, G. W. (1967) ‘Oropharynx’. In Cancer of the head and neck (MacComb, W. S., Fletcher, G. H., eds). Williams & Wilbrams Co: Baltimore, p. 179–212.Google Scholar
Gardner, M. J., Altman, D. G. (1989) Statistics with confidence. London: British Medical Journal.Google Scholar
Jennotte, J. C., Iskandar, S. S., Dalldorf, G. (1983) ‘Pathologic differentiation between lupus and nonlupus membranous gbmerulopathy’. Kidney International 24: 337–385.Google Scholar
Kramer, S., Gelber, R. D., Snow, J. B., Marcial, V. A., Lowry, L. D., Davis, L. W., Chandler, R. (1987) ‘Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73–03 of the radiation therapy oncology group’. Head and Neck Surgery 10: 19–30.Google Scholar
Lederman, M. (1967) ‘Cancer of the pharynx’. Journal of Laryngology and Otology 81: 151–172.Google Scholar
Marcial, V. A., Hanley, J. A., Ydrach, A., Vallecillo, L. A. (1980) ‘Tolerance of surgery after radical radiotherapy of carcinoma of the oropharynx’. Cancer, 46: 1910–1912.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., Smith, P. G. (1977) ‘Design and analysis of randomized clinical trials requiring prolonged observation of each patient’. British Journal of Cancer 35: 1–39.Google Scholar
Ricci, S B., Grandi, C., Salvatori, P. (1986) ‘On the problem of radiotherapy in the treatment of oropharyngeal carcinoma; salvage surgery’. Rays (Roma) 11, 127–131.Google Scholar
Rubin, P. (1971) Cancer of the head and neck: Oropharynx. Journal of the American Medical Association, 217: 940–942.CrossRefGoogle ScholarPubMed
Sagerman, R. H., Chung, T. Chung, Cummings, C. W., King, G. A., Rabuzzi, D. D., Reed, G. F. (1978) ‘Surgical salvage after failure of radiation therapy in patients with advanced cancer of the oral cavity and oropharynx’. Journal of Laryngology and Otology, 92:51–56.CrossRefGoogle ScholarPubMed
Silver, C. E., Nadler, B., Croft, C. B. (1978) ‘Oral and oropharyngeal carcinoma’. Archives of Otolaryngology, 104: 278–281.CrossRefGoogle ScholarPubMed
Snow, G. B., Annyas, A. A., Van Slooten, E. A., Bartelink, H., Hart, A. A. M. (1982). ‘Prognostic factors of neck node metastases’. Clinical Otolaryngology, 7: 185–192.CrossRefGoogle Scholar
Thawley, S. E. (1986) ‘Malignant neoplasms of the oropharynx’. In: Otolaryngology–Head and Neck Surgery. (Cummings, C. W., ed), The C. V. Mosby Co, St Louis, p. 1345–1398.Google Scholar
UICC (1987) International Union Against Cancer. TNM Classification of Malignant Tumours. (Hermanek, P., Sobin, L. H., eds), 4th edition. Springer-Verlag: Heidelberg.Google Scholar